George Elston | CFO |
Nancy Lurker | President & CEO |
Jay Duker | COO |
Scott Jones | Chief Commercial Officer |
Jennifer Kim | Cantor Fitzgerald |
Georgi Yordanov | Cowen |
Eddie Hickman | Guggenheim Securities |
Yi Chen | H.C. Wainwright |
Yale Jen | Laidlaw & Company |
Good morning. My name is Jonathan. And I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Development's conference call. There will be a question-and-answer session to follow at the completion of the prepared remarks.